BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 13/05/2015

FDA Clears Sulfacetamide Sodium Drug Products for Sale

The US Food and Drug Administration (FDA) has ruled that Sulfacetamide Sodium ophthalmic solution and ointment were not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving Abbreviated New Drug Applications (ANDAs) for these products.

Source: Federal Register — Food and Drug AdministrationOpen original release →